Future research should consider the functional role of FOXO1 in chemoresistance and the concrete mechanism of ADAMTS9-AS2 (such as the phosphoinositide 3-kinase/Akt pathway) in the pathogenesis of ccRCC. This evidence concerns the gene ADAMTS9 and nonpapillary renal cell carcinoma.